Annual CFI
-$302.40 K
+$173.30 K+36.43%
31 December 2023
Summary:
Predictive Oncology annual cash flow from investing activities is currently -$302.40 thousand, with the most recent change of +$173.30 thousand (+36.43%) on 31 December 2023. During the last 3 years, it has fallen by -$134.90 thousand (-80.54%).POAI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
+$6500.00+100.00%
30 September 2024
Summary:
Predictive Oncology quarterly cash flow from investing activities is currently $0.00, with the most recent change of +$6500.00 (+100.00%) on 30 September 2024. Over the past year, it has dropped by -$242.70 thousand (-100.00%). POAI quarterly CFI is now -100.00% below its all-time high of $971.10 thousand, reached on 30 September 2016.POAI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$248.80 K
-$242.70 K-3978.69%
30 September 2024
Summary:
Predictive Oncology TTM cash flow from investing activities is currently -$248.80 thousand, with the most recent change of -$242.70 thousand (-3978.69%) on 30 September 2024. Over the past year, it has dropped by -$122.20 thousand (-96.52%). POAI TTM CFI is now -130.02% below its all-time high of $828.90 thousand, reached on 31 March 2018.POAI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.4% | -100.0% | -96.5% |
| 3 y3 years | -80.5% | +100.0% | +74.1% |
| 5 y5 years | +72.8% | +100.0% | +84.5% |
POAI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.5% | +97.2% | -100.0% | +100.0% | -3978.7% | +97.7% |
| 5 y | 5 years | -80.5% | +97.2% | -100.0% | +100.0% | -446.0% | +97.7% |
| alltime | all time | <-9999.0% | +97.2% | -100.0% | +100.0% | -130.0% | +97.7% |
Predictive Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$248.80 K(+3978.7%) |
| June 2024 | - | -$6500.00(+116.7%) | -$6100.00(-97.6%) |
| Mar 2024 | - | -$3000.00(-98.7%) | -$258.70 K(-14.4%) |
| Dec 2023 | -$302.40 K(-36.4%) | -$239.30 K(-198.6%) | -$302.30 K(+138.8%) |
| Sept 2023 | - | $242.70 K(-193.7%) | -$126.60 K(-75.3%) |
| June 2023 | - | -$259.10 K(+456.0%) | -$513.00 K(+16.0%) |
| Mar 2023 | - | -$46.60 K(-26.7%) | -$442.10 K(-7.1%) |
| Dec 2022 | -$475.70 K(-95.5%) | -$63.60 K(-55.7%) | -$475.70 K(-95.3%) |
| Sept 2022 | - | -$143.70 K(-23.6%) | -$10.20 M(-0.4%) |
| June 2022 | - | -$188.20 K(+134.7%) | -$10.24 M(-0.5%) |
| Mar 2022 | - | -$80.20 K(-99.2%) | -$10.29 M(-2.9%) |
| Dec 2021 | -$10.61 M(+6232.8%) | -$9.79 M(+5147.9%) | -$10.61 M(+1003.1%) |
| Sept 2021 | - | -$186.50 K(-22.5%) | -$961.60 K(+7.9%) |
| June 2021 | - | -$240.70 K(-38.8%) | -$891.30 K(+68.8%) |
| Mar 2021 | - | -$393.10 K(+178.2%) | -$528.10 K(+215.3%) |
| Dec 2020 | -$167.50 K(-72.0%) | -$141.30 K(+21.6%) | -$167.50 K(+400.0%) |
| Sept 2020 | - | -$116.20 K(-194.9%) | -$33.50 K(-146.6%) |
| June 2020 | - | $122.50 K(-476.9%) | $71.90 K(-1142.0%) |
| Mar 2020 | - | -$32.50 K(+345.2%) | -$6900.00(-98.8%) |
| Dec 2019 | -$599.10 K(-46.1%) | -$7300.00(-32.4%) | -$599.10 K(-62.7%) |
| Sept 2019 | - | -$10.80 K(-124.7%) | -$1.61 M(-7.5%) |
| June 2019 | - | $43.70 K(-107.0%) | -$1.74 M(-7.7%) |
| Mar 2019 | - | -$624.70 K(-38.4%) | -$1.88 M(+69.4%) |
| Dec 2018 | -$1.11 M(-32.8%) | -$1.01 M(+619.0%) | -$1.11 M(+1415.3%) |
| Sept 2018 | - | -$141.10 K(+40.1%) | -$73.30 K(-109.9%) |
| June 2018 | - | -$100.70 K(-169.2%) | $740.20 K(-10.7%) |
| Mar 2018 | - | $145.60 K(+535.8%) | $828.90 K(-150.1%) |
| Dec 2017 | -$1.65 M | $22.90 K(-96.6%) | -$1.65 M(+10.6%) |
| Sept 2017 | - | $672.40 K(-5703.3%) | -$1.50 M(+25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$12.00 K(-99.5%) | -$1.20 M(+27.2%) |
| Mar 2017 | - | -$2.34 M(-1392.3%) | -$940.50 K(+122.4%) |
| Dec 2016 | -$422.90 K(+597.9%) | $180.80 K(-81.4%) | -$422.90 K(-34.0%) |
| Sept 2016 | - | $971.10 K(+298.0%) | -$640.50 K(-60.6%) |
| June 2016 | - | $244.00 K(-113.4%) | -$1.63 M(-13.0%) |
| Mar 2016 | - | -$1.82 M(+4842.4%) | -$1.87 M(+2993.6%) |
| Dec 2015 | -$60.60 K(-50.0%) | -$36.80 K(+130.0%) | -$60.50 K(+167.7%) |
| Sept 2015 | - | -$16.00 K(<-9900.0%) | -$22.60 K(-45.8%) |
| June 2015 | - | $0.00(-100.0%) | -$41.70 K(-1.4%) |
| Mar 2015 | - | -$7700.00(-800.0%) | -$42.30 K(-65.1%) |
| Dec 2014 | -$121.20 K(-43.9%) | $1100.00(-103.1%) | -$121.20 K(-48.8%) |
| Sept 2014 | - | -$35.10 K(+5750.0%) | -$236.60 K(-3.4%) |
| June 2014 | - | -$600.00(-99.3%) | -$245.00 K(-19.1%) |
| Mar 2014 | - | -$86.60 K(-24.2%) | -$302.80 K(+40.1%) |
| Dec 2013 | -$216.10 K(<-9900.0%) | -$114.30 K(+162.8%) | -$216.20 K(+112.2%) |
| Sept 2013 | - | -$43.50 K(-25.5%) | -$101.90 K(+74.5%) |
| June 2013 | - | -$58.40 K(<-9900.0%) | -$58.40 K(<-9900.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00 | $0.00 |
| Dec 2008 | -$41.90 K | - | - |
FAQ
- What is Predictive Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Predictive Oncology?
- What is Predictive Oncology annual CFI year-on-year change?
- What is Predictive Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Predictive Oncology?
- What is Predictive Oncology quarterly CFI year-on-year change?
- What is Predictive Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Predictive Oncology?
- What is Predictive Oncology TTM CFI year-on-year change?
What is Predictive Oncology annual cash flow from investing activities?
The current annual CFI of POAI is -$302.40 K
What is the all time high annual CFI for Predictive Oncology?
Predictive Oncology all-time high annual cash flow from investing activities is $0.00
What is Predictive Oncology annual CFI year-on-year change?
Over the past year, POAI annual cash flow from investing activities has changed by +$173.30 K (+36.43%)
What is Predictive Oncology quarterly cash flow from investing activities?
The current quarterly CFI of POAI is $0.00
What is the all time high quarterly CFI for Predictive Oncology?
Predictive Oncology all-time high quarterly cash flow from investing activities is $971.10 K
What is Predictive Oncology quarterly CFI year-on-year change?
Over the past year, POAI quarterly cash flow from investing activities has changed by -$242.70 K (-100.00%)
What is Predictive Oncology TTM cash flow from investing activities?
The current TTM CFI of POAI is -$248.80 K
What is the all time high TTM CFI for Predictive Oncology?
Predictive Oncology all-time high TTM cash flow from investing activities is $828.90 K
What is Predictive Oncology TTM CFI year-on-year change?
Over the past year, POAI TTM cash flow from investing activities has changed by -$122.20 K (-96.52%)